Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-26 @ 11:12 PM
Ignite Modification Date:
2025-12-26 @ 11:12 PM
NCT ID:
NCT00044512
Brief Summary:
Evaluate anti-cancer activity (e.g. proportion of patients with confirmed complete response or partial response) in patients with advanced, inoperable biopsy-proven hepatocellular carcinoma.
Detailed Description:
In addition to the key secondary outcome parameters the following exploratory parameters were evaluated in subpopulations:
* Pharmacokinetics (PK) profile of Sorafenib
* Plasma and tissue tumor biomarkers
Study:
NCT00044512
Study Brief:
Protocol Section:
NCT00044512